Status:
COMPLETED
Screening TO Prevent ColoRectal Cancer (STOP CRC) Among At-Risk Chinese and Korean American Primary Care Patients
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Thomas Jefferson University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
The objective of the study is to conduct a randomized controlled trial to determine the impact of a multi-level culturally-sensitive decision support intervention on colorectal cancer screening adhere...
Detailed Description
This study culturally adapts existing evidence-based decision support navigation intervention and tests its efficacy among 200 Chinese and Korean American men and 200 Chinese and Korean American women...
Eligibility Criteria
Inclusion
- Male and female Chinese and Korean American patients aged 50 to 75, who are not up to date for colorectal cancer screening
Exclusion
- Those with a family history, previous history of removing polyps, inflammatory bowel disease, or diagnosis of colorectal cancer screening.
Key Trial Info
Start Date :
August 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03481296
Start Date
August 20 2018
End Date
June 30 2021
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Irvine
Irvine, California, United States, 92697